Please search for your last name

Kings College London
Department of Diabetes Research
Oregon Health & Science University
Biomedical Engineering
Peter G. Jacobs, PhD is an Associate Professor in the Department of Biomedical Engineering at Oregon Health & Science University (OHSU) where he directs the Artificial Intelligence for Medical Systems (AIMS) lab (www.ohsu.edu/jacobs, @aimslabnews). He received his Ph.D. in electrical engineering from OHSU, his masters in electrical and computer engineering from the University of Wisconsin in Madison, and his bachelors in engineering from Swarthmore College. His interests are in the area of medical device design, ubiquitous sensing technologies, machine learning, control systems, decision support, and signal processing as applied toward type 1 diabetes technologies. The AIMS lab is focused on developing advanced control systems for automating delivery of insulin, glucagon and other hormones and evaluating these systems in people with type 1 diabetes. In recent years, the focus has been on integrating exercise metrics into decision support and closed loop systems and in developing machine learning algorithms to predict hypoglycemia during sleep, during exercise, and in general under free-living conditions. In addition to his academic work, he has been an early contributor to a number of diabetes technology companies including Dexcom and iSense (now Waveform), and is a co-founder of Pacific Diabetes Technologies.
no photo
University of British Columbia
Endocrinology
no photo
Hospital Universitario Doctor Peset
Servicio de Endocrinología y Nutrición
no photo
University Children’s Hospital
Endocrinology and Genetics
no photo
Fundación Santa Fe de Bogota
Endocrinology
no photo
Medical University Of Silesia SUM, Katowice, Poland
Dept. of Children's Diabetology
no photo
Örebro University
Dept of Medical Sciences
no photo
University of Tuebingen, Institute of Biomedical Engineering
Department of Medical Technologies and Regenerative Medicine
no photo
Cleveland Clinic
Radiology
no photo
Eli Lilly and Company
Diabetes